Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 737.95
-20.75 (-2.73%)
At close: Aug 1, 2025, 3:30 PM IST
Accolade Market Cap
Anthem Biosciences has a market cap or net worth of 414.69 billion as of August 1, 2025.
Market Cap
414.69B
Enterprise Value
408.50B
Revenue
18.50B
Ranking
n/a
PE Ratio
91.84
Stock Price
$737.95
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 414.69B, an increase of 1.10%. That is a compound annual growth rate of 43.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 414.69B | -2.73% |
| Jul 31, 2025 | 426.35B | -1.49% |
| Jul 30, 2025 | 432.80B | -1.51% |
| Jul 29, 2025 | 439.43B | 3.51% |
| Jul 28, 2025 | 424.52B | -0.19% |
| Jul 25, 2025 | 425.34B | -0.13% |
| Jul 24, 2025 | 425.87B | 0.28% |
| Jul 23, 2025 | 424.69B | 3.24% |
| Jul 22, 2025 | 411.38B | 0.29% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,104.06B |
| Divi's Laboratories | 1,772.40B |
| Cipla | 1,271.40B |
| Apollo Hospitals Enterprise | 1,072.06B |
| Mankind Pharma | 1,054.40B |
| Zydus Lifesciences | 1,001.05B |
| Aurobindo Pharma | 672.63B |
| Fortis Healthcare | 642.17B |